Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More Analysis and Commentary 5/17/18 Analysis and Commentary 5/17/18 House Recommends Major Increase in BA Funding Read More Advocacy at a Glance 2/3/17 Advocacy at a Glance 2/3/17 Advocacy at a Glance Read More Analysis and Commentary 1/6/17 Analysis and Commentary 1/6/17 The Speedy Appointment of a New Commissioner? Read More Advocacy at a Glance 1/6/17 Advocacy at a Glance 1/6/17 Advocacy at a Glance Read More Advocacy at a Glance 10/16/15 Advocacy at a Glance 10/16/15 Combination Products: an Expanding Area of FDA Responsibility and more Read More
Analysis and Commentary 4/3/21 Analysis and Commentary 4/3/21 Legal Limitations on Appointment of New FDA Commissioner Read More
Advocacy at a Glance 4/3/21 Advocacy at a Glance 4/3/21 Acting FDA Commissioner Dr. Janet Woodcock will address the Alliance on April 14. The President’s FY 22 Budget Preview has not yet been released. Read More
Analysis and Commentary 5/17/18 Analysis and Commentary 5/17/18 House Recommends Major Increase in BA Funding Read More
Analysis and Commentary 1/6/17 Analysis and Commentary 1/6/17 The Speedy Appointment of a New Commissioner? Read More
Advocacy at a Glance 10/16/15 Advocacy at a Glance 10/16/15 Combination Products: an Expanding Area of FDA Responsibility and more Read More
